Description
The Department of Veterans Affairs (DVA) Network Contracting Office NCO2 intends to award a sole source contract to Nova Biomedical Corp for Point of Care (POC) Glucose Hospital Meter Systems for Cost Per Test (CPT) services. The system must be FDA approved and CLIA waived for all patient types, including critically ill. The contract includes meters, reagents, standards, controls, and peripherals necessary for the generation of fingerstick glucose cost per test (CPT) services. The following medical centers have a recurring requirement for these systems: James J. Peters VA Medical Center, East Orange VA Medical Center, Castle Point VA Medical Center, Brooklyn VA Medical Center, Margaret Cochran VA Medical Center, and Northport VA Medical Center.
• The system must be U.S. Food & Drug Administration (FDA) approved and Clinical Laboratory Improvement Amendments (CLIA) of 1988 waived for all patient types.
• The system is inclusive of meters, reagents, standards, controls, other items required for proper operation of testing meters as well as peripherals necessary for the generation of fingerstick glucose cost per test (CPT) services.
• Market research was conducted, and Nova Biomedical Corporation is the sole vendor capable of meeting the requirement.
• Capability statements must be received by June 18, 2026, 10:00 AM Eastern Standard Time.